CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.04 HKD | +1.61% |
|
+5.22% | -1.75% |
| 04-24 | China Resources Pharmaceutical Group Limited Announces Change of Company Secretary | CI |
| 04-18 | China Resources Pharma Unit Issues 3 Billion Yuan Bonds | MT |
| Sales 2024 * | 280B 35.79B 2,865B | Sales 2025 * | 312B 39.8B 3,187B | Capitalization | 31.66B 4.04B 324B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.56B 583M 46.69B | Net income 2025 * | 5.11B 653M 52.24B | EV / Sales 2024 * | 0.23 x |
| Net Debt 2024 * | 32.96B 4.21B 337B | Net Debt 2025 * | 31.69B 4.05B 324B | EV / Sales 2025 * | 0.2 x |
| P/E ratio 2024 * |
7.09
x | P/E ratio 2025 * |
6.27
x | Employees | 72,986 |
| Yield 2024 * |
3.27% | Yield 2025 * |
3.66% | Free-Float | 27.95% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.61% | ||
| 1 week | +5.22% | ||
| Current month | +0.80% | ||
| 1 month | -2.51% | ||
| 3 months | +0.60% | ||
| 6 months | +5.00% | ||
| Current year | -1.75% |
1 week
4.72
5.07
1 month
4.625.18
Current year
4.455.56
1 year
4.458.13
3 years
3.188.13
5 years
3.1811.76
10 years
3.1813.16
| Managers | Title | Age | Since |
|---|---|---|---|
Xiao Song Bai
CEO | Chief Executive Officer | 52 | 13/01/22 |
Rong Hui Deng
DFI | Director of Finance/CFO | 46 | 12/06/23 |
Yue Wei Han
CHM | Chairman | 56 | 21/10/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 56 | 31/05/16 |
Ke Jian Zhang
BRD | Director/Board Member | 68 | 19/06/16 |
Kin Fun Kwok
BRD | Director/Board Member | 75 | 19/06/16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.92% | 4 M€ | -27.92% | ||
| 0.52% | 2 M€ | -16.59% | - | |
| 0.12% | 4 M€ | -11.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 5.04 | +1.61% | 9,960,034 |
| 25/04/24 | 4.96 | +1.64% | 10,384,830 |
| 24/04/24 | 4.88 | +2.52% | 7,079,220 |
| 23/04/24 | 4.76 | -1.65% | 10,082,070 |
| 22/04/24 | 4.84 | +1.04% | 8,786,161 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.
Sector
Pharmaceuticals
Calendar
21/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
5.04
HKD
Average target price
7.406
HKD
Spread / Average Target
+46.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.75% | 4.04B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 3320 Stock
